June 08, 2010; 74 (23) Articles
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.-M. Dosch, R. Cheung, D. Gagne, C. D'Souza, M. Ursell, P. O'Connor
First published April 28, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181e1cec2
J.M. Burton
S. Kimball
R. Vieth
A. Bar-Or
H.-M. Dosch
R. Cheung
D. Gagne
C. D'Souza
M. Ursell
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.-M. Dosch, R. Cheung, D. Gagne, C. D'Souza, M. Ursell, P. O'Connor
Neurology Jun 2010, 74 (23) 1852-1859; DOI: 10.1212/WNL.0b013e3181e1cec2
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 74 no. 23 1852-1859
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published April 28, 2010.
Article Versions
- Previous version (April 28, 2010 - 13:00).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2010
Author Disclosures
- J.M. Burton, MD, MSc, FRCPC,
- S. Kimball, MSc, MLT,
- R. Vieth, PhD,
- A. Bar-Or, MD, MSc, FRCPC,
- H.-M. Dosch, MD, PhD,
- R. Cheung, MSc,
- D. Gagne,
- C. D'Souza, PhD,
- M. Ursell, MS, MSc, FRCPC and
- P. O'Connor, MS, MSc, FRCPC
- J.M. Burton, MD, MSc, FRCPC,
- S. Kimball, MSc, MLT,
- R. Vieth, PhD,
- A. Bar-Or, MD, MSc, FRCPC,
- H.-M. Dosch, MD, PhD,
- R. Cheung, MSc,
- D. Gagne,
- C. D'Souza, PhD,
- M. Ursell, MS, MSc, FRCPC and
- P. O'Connor, MS, MSc, FRCPC
- From the Division of Neurology (J.M.B., P.O.), St. Michael's Hospital, Toronto; University of Toronto (J.M.B., S.K., R.V., H.-M.D., R.C., C.D., P.O.), Toronto; Department of Nutritional Sciences and Laboratory Medicine and Pathology (S.K., R.V.), Mount Sinai Hospital, Toronto; Montreal Neurological Institute (A.B.-O., D.G.), Montreal; McGill University (A.B.-O., D.G.), Montreal; The Neurosciences & Mental Health Program (H.-M.D., R.C.), Hospital for Sick Children, Toronto; Center for Research in Neurodegenerative Diseases (C.D.), University of Toronto; and Division of Neurology (M.U.), Etobicoke General Hospital, Toronto, Canada.
- Address correspondence and reprint requests to Dr. Jodie M. Burton, Department of Clinical Neurosciences, Rockyview General Hospital, 5th Floor, Room 5A214, 7007 14th Street SW, Calgary, Alberta T2V 1P9, Canada jodie.burton{at}albertahealthservices.ca
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan